Castor and Cratos Branched Aortic Grafts Registry for Thoracic Aortic Pathologies

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The CEDAR registry is an observational, multi-center study that combines retrospective and prospective data. It aims to track safety and performance of Castor and Cratos branched stent grafts used in endovascular treatment of thoracic aortic pathologies in the descending aorta. The study plans to enroll about 100 patients across European hospitals and follows them over short, medium, and long-term periods. Data collection includes real-world outcomes, device performance, and any complications related to the implants. It is sponsored by Shanghai MicroPort Endovascular MedTech Group, with participating sites in Hamburg, Münster, and Sion.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Implantation of a Castor™ or Cratos™ single branch endoprothesis with incorporation of the left subclavian artery
* Age \>18 years

Exclusion Criteria:

* Patients allergic to the materials of the device;
* Patients with severe or potentially systemic infections that increase the chance of graft infection;
* Minors and pregnant women;
* Branch for other supra-aortic vessels than the LSA
* Rejection of participation.

Where it's running

• ASKLEPIOS Kliniken St. Georg
  Hamburg, Germany Recruiting
• Universitätsklinikum Münster (UKM)
  Münster, Germany Recruiting
• Hôpital de Sion
  Sion, Switzerland Recruiting
• Universitätsspital Zürich (USZ)
  Zurich, Switzerland Recruiting

Study contacts

• Study coordinator: Maggie Shen, MD MSc
• Email: maggie.shen@endovastec-lm.com
• Phone: 00441235750800

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• GORE MBA Arch Endoprosthesis Early Feasibility Study

  This study tests the safety of the MBA device in people with arch-related thoracic aortic diseases to see if it can be used safely in real-world settings.

  Recruiting at 3 sites W.L.Gore & Associates · Los Angeles, California and 2 other locations · NCT07564375

• Rapidlink device for repairing aortic arch branch vessels during open thoracic aorta surgery

  This study will test whether the Rapidlink device can help surgeons repair or replace the arteries branching from the aortic arch during open surgery for thoracic aortic disease.

  Recruiting at 7 sites Vascutek Ltd. · Los Angeles, California and 20 other locations · NCT07078383

• TBE stent-graft repair for thoracic aortic disease with Zone 2 proximal landing in Japan

  This project will try the GORE TAG Thoracic Branch stent graft in people in Japan who need repair of descending thoracic aortic aneurysm, traumatic transection, or complicated type B dissection with a proximal landing in Zone 2.

  Recruiting W.L.Gore & Associates · Osaka, Suita · NCT07049913

• Digital Twin and ML-Driven Modeling of TEVAR Procedures

  Aims to collect anonymized patient data and CT scans from people undergoing TEVAR to build a digital twin that can simulate results and help doctors choose devices and plan procedures.

  Recruiting Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Milan · NCT07640828

• Long-term outcomes after GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System

  This registry will follow adults who receive the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL after TEVAR to see how they do over ten years.

  Recruiting at 32 sites W.L.Gore & Associates · Tucson, Arizona and 36 other locations · NCT06658730

• Treatment for Thoracic Aortic Aneurysms and Valve Conditions

  This study is trying to see if surgery is the right choice for patients with slightly enlarged aortas and specific heart valve conditions, to help improve treatment guidelines for thoracic aortic aneurysms.

  Recruiting Tomsk National Research Medical Center of the Russian Academy of Sciences · Tomsk and 1 other locations · NCT04372563

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.